RespiriTB-876090 In vitro activity of single HDT compounds report

Summary

In vitro activity of single HDT compounds report will summarize the results of in vitro activity of single Host Directed Therapeutics compounds against intracellular MDRMtb strains in human cells

More information & hyperlinks

Web resources:

https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5ece8dc42&appId=PPGMS

Associated projects

RespiriTB - Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

Organisations

Not specified